Related content

KRAS and BRAF Mutational Status in Primary Colorectal Tumors and Related Metastatic Sites: Biological and Clinical Implications

By Italiano Antoine  

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1429-1434

Springer Publishing Company

Access to resources Recommend Favorite

KRAS mutational status analysis of peripheral blood isolated circulating tumor cells in metastatic colorectal patients

By          

Oncology Letters, Vol. 6, Iss. 5, 2013-01 ,pp. : 1343-1345

Spandidos Publications

Access to resources Recommend Favorite

Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma

By Spindler Karen-Lise G.   Sorensen Morten M.   Pallisgaard Niels   Andersen Rikke F.   Havelund Birgitte M.   Ploen John   Lassen Ulrik   Jakobsen Anders K. M.  

Acta Oncologica, Vol. 52, Iss. 5, 2013-06 ,pp. : 963-970

Informa Healthcare

Access to resources Recommend Favorite

Concordant KRAS Mutations in Primary and Metastatic Colorectal Cancer Tissue Specimens: A Meta-Analysis and Systematic Review

By Han Cheng-Bo   Li Fan   Ma Jie-Tao   Zou Hua-Wei  

Cancer Investigation, Vol. 30, Iss. 10, 2012-12 ,pp. : 741-747

Informa Healthcare

Access to resources Recommend Favorite

Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases

By Kaneko Yuka   Kuramochi Hidekazu   Nakajima Go   Inoue Yuji   Yamamoto Masakazu  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 113-120

Springer Publishing Company

Access to resources Recommend Favorite